Skip to main content

Enhanced Immune Responses to HIV-1 Envelope Elicited by a Vaccine Regimen Consisting of Priming with Newcastle Disease Virus Expressing HIV gp160 and Boosting with gp120 and SOSIP gp140 Proteins.

Publication ,  Journal Article
Khattar, SK; DeVico, AL; LaBranche, CC; Panda, A; Montefiori, DC; Samal, SK
Published in: J Virol
February 1, 2016

Newcastle disease virus (NDV) expressing HIV-1 BaL gp160 was evaluated either alone or with monomeric BaL gp120 and BaL SOSIP gp140 protein in a prime-boost combination in guinea pigs to enhance envelope (Env)-specific humoral and mucosal immune responses. We showed that a regimen consisting of an NDV prime followed by a protein boost elicited stronger serum and mucosal Th-1-biased IgG responses and neutralizing antibody responses than NDV-only immunizations. Additionally, these responses were higher after the gp120 than after the SOSIP gp140 protein boost.

Duke Scholars

Published In

J Virol

DOI

EISSN

1098-5514

Publication Date

February 1, 2016

Volume

90

Issue

3

Start / End Page

1682 / 1686

Location

United States

Related Subject Headings

  • env Gene Products, Human Immunodeficiency Virus
  • Virology
  • Vaccines, Synthetic
  • Vaccination
  • Th1 Cells
  • Newcastle disease virus
  • Neutralization Tests
  • Injections, Intramuscular
  • Immunoglobulin G
  • Immunization Schedule
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Khattar, S. K., DeVico, A. L., LaBranche, C. C., Panda, A., Montefiori, D. C., & Samal, S. K. (2016). Enhanced Immune Responses to HIV-1 Envelope Elicited by a Vaccine Regimen Consisting of Priming with Newcastle Disease Virus Expressing HIV gp160 and Boosting with gp120 and SOSIP gp140 Proteins. J Virol, 90(3), 1682–1686. https://doi.org/10.1128/JVI.02847-15
Khattar, Sunil K., Anthony L. DeVico, Celia C. LaBranche, Aruna Panda, David C. Montefiori, and Siba K. Samal. “Enhanced Immune Responses to HIV-1 Envelope Elicited by a Vaccine Regimen Consisting of Priming with Newcastle Disease Virus Expressing HIV gp160 and Boosting with gp120 and SOSIP gp140 Proteins.J Virol 90, no. 3 (February 1, 2016): 1682–86. https://doi.org/10.1128/JVI.02847-15.

Published In

J Virol

DOI

EISSN

1098-5514

Publication Date

February 1, 2016

Volume

90

Issue

3

Start / End Page

1682 / 1686

Location

United States

Related Subject Headings

  • env Gene Products, Human Immunodeficiency Virus
  • Virology
  • Vaccines, Synthetic
  • Vaccination
  • Th1 Cells
  • Newcastle disease virus
  • Neutralization Tests
  • Injections, Intramuscular
  • Immunoglobulin G
  • Immunization Schedule